HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Trained Immunity and Reactivity of Macrophages and Endothelial Cells.

Abstract
Innate immune cells can develop exacerbated immunologic response and long-term inflammatory phenotype following brief exposure to endogenous or exogenous insults, which leads to an altered response towards a second challenge after the return to a nonactivated state. This phenomenon is known as trained immunity (TI). TI is not only important for host defense and vaccine response but also for chronic inflammations such as cardiovascular and metabolic diseases such as atherosclerosis. TI can occur in innate immune cells such as monocytes/macrophages, natural killer cells, endothelial cells (ECs), and nonimmune cells, such as fibroblast. In this brief review, we analyze the significance of TI in ECs, which are also considered as innate immune cells in addition to macrophages. TI can be induced by a variety of stimuli, including lipopolysaccharides, BCG (bacillus Calmette-Guerin), and oxLDL (oxidized low-density lipoprotein), which are defined as risk factors for cardiovascular and metabolic diseases. Furthermore, TI in ECs is functional for inflammation effectiveness and transition to chronic inflammation. Rewiring of cellular metabolism of the trained cells takes place during induction of TI, including increased glycolysis, glutaminolysis, increased accumulation of tricarboxylic acid cycle metabolites and acetyl-coenzyme A production, as well as increased mevalonate synthesis. Subsequently, this leads to epigenetic remodeling, resulting in important changes in chromatin architecture that enables increased gene transcription and enhanced proinflammatory immune response. However, TI pathways and inflammatory pathways are separated to ensure memory stays when inflammation undergoes resolution. Additionally, reactive oxygen species play context-dependent roles in TI. Therefore, TI plays significant roles in EC and macrophage pathology and chronic inflammation. However, further characterization of TI in ECs and macrophages would provide novel insights into cardiovascular disease pathogenesis and new therapeutic targets. Graphic Abstract: A graphic abstract is available for this article.
AuthorsCharles Drummer 4th, Fatma Saaoud, Ying Shao (邵颖), Yu Sun (孙宇), Keman Xu (徐克曼), Yifan Lu (路一凡), Dong Ni (倪栋), Diana Atar, Xiaohua Jiang (蒋晓华), Hong Wang (王虹), Xiaofeng Yang
JournalArteriosclerosis, thrombosis, and vascular biology (Arterioscler Thromb Vasc Biol) Vol. 41 Issue 3 Pg. 1032-1046 (03 2021) ISSN: 1524-4636 [Electronic] United States
PMID33380171 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)
Chemical References
  • Cytokines
  • Reactive Oxygen Species
Topics
  • Animals
  • Cardiovascular Diseases (etiology, immunology)
  • Cytokines (biosynthesis)
  • Endothelial Cells (immunology)
  • Energy Metabolism
  • Epigenesis, Genetic
  • Humans
  • Immunity, Innate
  • Immunologic Memory
  • Infections (etiology, immunology)
  • Inflammation (etiology, immunology)
  • Macrophages (immunology)
  • Metabolic Diseases (etiology, immunology)
  • Metabolic Networks and Pathways (immunology)
  • Models, Immunological
  • Reactive Oxygen Species (metabolism)
  • Reperfusion Injury (etiology, immunology)
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: